FI963329L - Nitroglyseriinin transdermaalinen antomuoto ei-toivotun synnytyksen estämiseksi - Google Patents

Nitroglyseriinin transdermaalinen antomuoto ei-toivotun synnytyksen estämiseksi Download PDF

Info

Publication number
FI963329L
FI963329L FI963329A FI963329A FI963329L FI 963329 L FI963329 L FI 963329L FI 963329 A FI963329 A FI 963329A FI 963329 A FI963329 A FI 963329A FI 963329 L FI963329 L FI 963329L
Authority
FI
Finland
Prior art keywords
nitroglycerin
birth
transdermal delivery
prevent unwanted
unwanted
Prior art date
Application number
FI963329A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963329A0 (fi
FI963329A7 (fi
Inventor
Hans-Michael Wolff
Dietrich Schacht
Martin Feelisch
Bruce Ramsay
John Francis Martin
Christoph Christopher Lees
Belder Adam Julian De
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of FI963329A0 publication Critical patent/FI963329A0/fi
Publication of FI963329A7 publication Critical patent/FI963329A7/fi
Publication of FI963329L publication Critical patent/FI963329L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Botany (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI963329A 1994-02-28 1995-02-23 Nitroglyseriinin transdermaalinen antomuoto ei-toivotun synnytyksen estämiseksi FI963329L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4406332A DE4406332C1 (de) 1994-02-28 1994-02-28 Pharmazeutische Verwendung von Nitroglycerin zur Verhinderung unerwünschter Wehentätigkeit bei Säugern in einer transdermalen Applikationsform
PCT/EP1995/000654 WO1995022964A1 (de) 1994-02-28 1995-02-23 Transdermale darreichungsform von nitroglycerin zur verhinderung unerwünschter wehentätigkeit

Publications (3)

Publication Number Publication Date
FI963329A0 FI963329A0 (fi) 1996-08-27
FI963329A7 FI963329A7 (fi) 1996-09-05
FI963329L true FI963329L (fi) 1996-09-05

Family

ID=6511303

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963329A FI963329L (fi) 1994-02-28 1995-02-23 Nitroglyseriinin transdermaalinen antomuoto ei-toivotun synnytyksen estämiseksi

Country Status (15)

Country Link
US (1) US5817697A (da)
EP (1) EP0804176B1 (da)
JP (1) JP2823700B2 (da)
KR (1) KR100334372B1 (da)
CN (1) CN1069522C (da)
AT (1) ATE200732T1 (da)
CA (1) CA2184201A1 (da)
DE (2) DE4406332C1 (da)
DK (1) DK0804176T3 (da)
ES (1) ES2156938T3 (da)
FI (1) FI963329L (da)
GR (1) GR3035785T3 (da)
NO (1) NO961724D0 (da)
PT (1) PT804176E (da)
WO (1) WO1995022964A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020015951A1 (en) * 2000-01-06 2002-02-07 Bader Joel S. Method of analyzing a nucleic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79183B (da) * 1983-04-27 1984-10-02 Lohmann Gmbh & Co Kg
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
WO1992022292A1 (de) * 1991-06-10 1992-12-23 Schwarz Pharma Ag Nitroglycerin-pflaster und verfahren zu seiner herstellung
US5508045A (en) * 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
JPH1192367A (ja) * 1997-09-22 1999-04-06 Hoechst Marion Roussel Kk 妊娠悪阻治療剤

Also Published As

Publication number Publication date
FI963329A0 (fi) 1996-08-27
CN1069522C (zh) 2001-08-15
ATE200732T1 (de) 2001-05-15
FI963329A7 (fi) 1996-09-05
JP2823700B2 (ja) 1998-11-11
GR3035785T3 (en) 2001-07-31
NO961724L (no) 1996-04-29
DE59509223D1 (de) 2001-05-31
DE4406332C1 (de) 1995-06-22
DK0804176T3 (da) 2001-05-28
NO961724D0 (no) 1996-04-29
KR960705553A (ko) 1996-11-08
CA2184201A1 (en) 1995-08-31
ES2156938T3 (es) 2001-08-01
US5817697A (en) 1998-10-06
EP0804176B1 (de) 2001-04-25
JPH09506108A (ja) 1997-06-17
CN1140990A (zh) 1997-01-22
EP0804176A1 (de) 1997-11-05
KR100334372B1 (ko) 2002-09-04
WO1995022964A1 (de) 1995-08-31
PT804176E (pt) 2001-08-30

Similar Documents

Publication Publication Date Title
DE69530004D1 (de) Transdermale verabreichung von apomorphin
FI950465L (fi) Läpäisevä laastari lääkityksen antamiseksi ihoon
FI955259L (fi) Estradiolia sisältävä transdermaalinen terapeuttinen systeemi
ID19755A (id) Komposisi untuk pemberian transdermal obat-obat steroid
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
ATE241350T1 (de) Transdermale verabreichungsform von flurbiprofen
EE9700241A (et) Farmatseutiline kompositsioon transdermaalseks manustamiseks
FI951295A7 (fi) Ihon läpi tapahtuva veressä olevien valoherkkien aineiden in vivo-akti vointi
DE69609353D1 (de) In der therapie verwendbare chinolin- und chinazolinverbindungen
EP0925046A4 (en) TOPICAL PREPARATIONS AND METHODS FOR TREATING HEMORRHOIDS
NO972412L (no) Antiparasitt-preparat for å behandle og beskytte kjæledyr
FI971412A7 (fi) Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasie n estäjinä
FI972542L (fi) Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista antamista varten
EP0964032A4 (en) NEW COMPOSITION AND TREATMENT
DE69526437D1 (de) Transdermal verabreichbare zubereitung zur behandlung von störungen des harnlassens
DE59500266D1 (de) Transdermales therapeutisches System zur Applikation von Naloxon
DK606987D0 (da) Brugeraktiveret transdermalt terapeutisk system
FI964936L (fi) Bentsopyraaneja ja niiden käyttö terapeuttisina aineina
FI973362L (fi) Transdermaalinen formula
NO964915D0 (no) Transdermal avlevering av antiepileptiske legemidler
IS1980B (is) Notkun Melatóníns til meðferðar lyfjafíkla
ID22378A (id) Komposisi untuk mencegah dan mengobati penyakit gusi
FI963329A7 (fi) Nitroglyseriinin transdermaalinen antomuoto ei-toivotun synnytyksen es tämiseksi
FR2760363B1 (fr) Composition pour le traitement topique des affections de la peau et des phaneres
DE69333009D1 (de) Transdermale verabreichung von ketorolac

Legal Events

Date Code Title Description
MA Patent expired